Relation between high serum hepcidin-25 level and subclinical atherosclerosis and cardiovascular mortality in hemodialysis patients

Ozlem Yayar; Baris Eser; Kılıç, Harun

DSpace Home
→
Fakülteler / Faculties
→
Tıp Fakültesi
→
Dahili Tıp Bilimleri / Internal Medıcal Scıences
→
Makale Koleksiyonu
→
View Item

dc.contributor.authors	Yayar, O; Eser, B; Kilic, H;
dc.date.accessioned	2020-02-27T08:27:43Z
dc.date.available	2020-02-27T08:27:43Z
dc.date.issued	2018
dc.identifier.citation	Yayar, O; Eser, B; Kilic, H; (2018). Relation between high serum hepcidin-25 level and subclinical atherosclerosis and cardiovascular mortality in hemodialysis patients. ANATOLIAN JOURNAL OF CARDIOLOGY, 19, 122-117
dc.identifier.issn	2149-2263
dc.identifier.uri	https://doi.org/10.14744/AnatolJCardiol.2017.8019
dc.identifier.uri	https://hdl.handle.net/20.500.12619/65994
dc.description.abstract	Conclusion: This study suggests that hepcidin is effective in cardiovascular mortality and pathophysiology of subclinical atherosclerosis in HD patients.
dc.language	English
dc.publisher	TURKISH SOC CARDIOLOGY
dc.rights	info:eu-repo/semantics/openAccess
dc.rights.uri	http://creativecommons.org/licenses/by/4.0/
dc.subject	Cardiovascular System & Cardiology
dc.title	Relation between high serum hepcidin-25 level and subclinical atherosclerosis and cardiovascular mortality in hemodialysis patients
dc.type	Article
dc.identifier.volume	19
dc.identifier.startpage	117
dc.identifier.endpage	122
dc.contributor.department	Sakarya Üniversitesi/Tıp Fakültesi/Dahili Tıp Bilimleri Bölümü
dc.contributor.saüauthor	Kılıç, Harun
dc.relation.journal	ANATOLIAN JOURNAL OF CARDIOLOGY
dc.identifier.wos	WOS:000429627800009
dc.identifier.doi	10.14744/AnatolJCardiol.2017.8019
dc.identifier.eissn	2149-2271
dc.contributor.author	Ozlem Yayar
dc.contributor.author	Baris Eser
dc.contributor.author	Kılıç, Harun